PMC:7408073 / 107622-107892 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T31 212-217 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T222 212-217 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
3670 189-197 Species denotes patients Tax:9606
3679 49-58 Chemical denotes CaNa2EDTA
3687 80-89 Disease denotes poisoning MESH:D011041

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T590 75-89 Disease denotes lead poisoning http://purl.obolibrary.org/obo/MONDO_0018019
T591 80-89 Disease denotes poisoning http://purl.obolibrary.org/obo/MONDO_0029000

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T84 212-217 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T85 212-217 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T86 238-242 http://purl.obolibrary.org/obo/CLO_0003535 denotes g/m2

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T533 0-270 Sentence denotes However, the FDA-approved method for delivery of CaNa2EDTA in treatment of lead poisoning is intravenously or intramuscularly and the recommended dose for asymptomatic adults and pediatric patients with elevated blood lead levels is 1000 g/m2/day (~0,05 g/kg/day) [190].